Walsh B T, Devlin M J
Department of Psychiatry, College of Physicians and Surgeons, Columbia University, USA.
Addict Behav. 1995 Nov-Dec;20(6):757-64. doi: 10.1016/0306-4603(95)00091-7.
This paper reviews the use of medication in the treatment of bulimia nervosa and of binge eating disorder. There is now compelling evidence from double blind, placebo-controlled studies that antidepressant medication is useful in the treatment of bulimia nervosa. What is less clear is which patients are most likely to benefit from antidepressant medications and how to best sequence the various therapeutic interventions available. The utility of antidepressant medications in bulimia nervosa has led to their evaluation in binge eating disorder. The limited information currently available suggests that antidepressant treatment may be associated with a reduction in binge frequency in obese patients with binge eating disorder, but does not lead to weight reduction. Additional studies of the use of medication in the treatment of binge eating disorder and of the role of pharmacotherapy in the treatment of bulimia nervosa are needed.
本文综述了药物在神经性贪食症和暴饮暴食症治疗中的应用。目前,双盲、安慰剂对照研究提供了令人信服的证据,表明抗抑郁药物对神经性贪食症的治疗有效。尚不清楚的是哪些患者最有可能从抗抑郁药物中获益,以及如何最佳地安排现有的各种治疗干预措施。抗抑郁药物在神经性贪食症中的效用促使人们对其在暴饮暴食症中的效果进行评估。目前有限的信息表明,抗抑郁治疗可能会使患有暴饮暴食症的肥胖患者的暴饮暴食频率降低,但不会导致体重减轻。需要进一步开展关于药物在暴饮暴食症治疗中的应用以及药物治疗在神经性贪食症治疗中的作用的研究。